Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
McKesson
Merck
Mallinckrodt

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Mikart Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MIKART, and what generic and branded alternatives to MIKART drugs are available?

MIKART has sixty-two approved drugs.



Summary for Mikart
US Patents:0
Tradenames:22
Ingredients:20
NDAs:62

Drugs and US Patents for Mikart

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 081097-001 Oct 26, 1990 DISCN No No   Start Trial   Start Trial
Mikart ESGIC-PLUS acetaminophen; butalbital; caffeine TABLET;ORAL 089451-001 May 23, 1988 DISCN No No   Start Trial   Start Trial
Mikart ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 081096-001 Oct 26, 1990 DISCN No No   Start Trial   Start Trial
Mikart OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040698-001 Apr 27, 2006 DISCN No No   Start Trial   Start Trial
Mikart MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040893-001 Jun 24, 2009 DISCN No No   Start Trial   Start Trial
Mikart ISONIAZID isoniazid SYRUP;ORAL 081118-001 Jul 21, 1997 DISCN No No   Start Trial   Start Trial
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 040458-001 Apr 25, 2003 RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Johnson and Johnson
Mallinckrodt
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.